Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Smith

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
BMC Medical Informatics and Decision Making|January 17, 2025
Implementation of a Laboratory Information Management System (LIMS) for microbiology in Timor-Leste: challenges, mitigation strategies, and end-user experiencesTessa Oakley, Juliao Vaz, Fausto da Silva, et al.
Vaccine Reports|June 6, 2017
Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of <i>Streptococcus pneumoniae</i> in Papua New Guinean children: A randomized controlled trialCelestine Aho, Audrey Michael, Mition Yoannes, et al.
BMJ Open|November 30, 2021
Simplified 0+1 and 1+1 pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam: protocol for a randomised controlled trialBeth Temple, Hau Phuc Tran, Vo Thi Trang Dai, et al.
BMC Pediatrics|March 9, 2021
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Frontiers in Pediatrics|March 6, 2015
Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori childrenAnne B Chang, Robyn L Marsh, John W Upham, et al.
BMJ Open|January 18, 2015
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathu Santosham, et al.
Pediatric Investigation|March 27, 2023
Can non-typeable <i>Haemophilus influenzae</i> carriage surveillance data infer antimicrobial resistance associated with otitis media?Sophia Bowman-Derrick, Tegan M Harris, Jemima Beissbarth, et al.
BMC Pharmacology & Toxicology|July 29, 2019
Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trialChristine Wigger, Amanda Jane Leach, Jemima Beissbarth, et al.
Molecular Genetics and Metabolism|March 31, 2004
Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase IMarshall L Summar, Lynn Hall, Brian Christman, et al.
Trials|September 10, 2013
Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trialKerry-Ann F O'Grady, Keith Grimwood, Allan Cripps, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
BMC Medical Informatics and Decision Making|January 17, 2025
Implementation of a Laboratory Information Management System (LIMS) for microbiology in Timor-Leste: challenges, mitigation strategies, and end-user experiencesTessa Oakley, Juliao Vaz, Fausto da Silva, et al.
Vaccine Reports|June 6, 2017
Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of <i>Streptococcus pneumoniae</i> in Papua New Guinean children: A randomized controlled trialCelestine Aho, Audrey Michael, Mition Yoannes, et al.
BMJ Open|November 30, 2021
Simplified 0+1 and 1+1 pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam: protocol for a randomised controlled trialBeth Temple, Hau Phuc Tran, Vo Thi Trang Dai, et al.
BMC Pediatrics|March 9, 2021
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Frontiers in Pediatrics|March 6, 2015
Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori childrenAnne B Chang, Robyn L Marsh, John W Upham, et al.
BMJ Open|January 18, 2015
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathu Santosham, et al.
Pediatric Investigation|March 27, 2023
Can non-typeable <i>Haemophilus influenzae</i> carriage surveillance data infer antimicrobial resistance associated with otitis media?Sophia Bowman-Derrick, Tegan M Harris, Jemima Beissbarth, et al.
BMC Pharmacology & Toxicology|July 29, 2019
Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trialChristine Wigger, Amanda Jane Leach, Jemima Beissbarth, et al.
Molecular Genetics and Metabolism|March 31, 2004
Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase IMarshall L Summar, Lynn Hall, Brian Christman, et al.
Trials|September 10, 2013
Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trialKerry-Ann F O'Grady, Keith Grimwood, Allan Cripps, et al.
Pageof 8